Picture of Nexalin Technology logo

NXL Nexalin Technology Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapSucker Stock

Annual cashflow statement for Nexalin Technology, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
2024
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:PROSPECTUSPROSPECTUS10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-3.4-6.08-1.7-4.65-7.61
Depreciation
Amortisation
Non-Cash Items2.034.480.1161.583.53
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital0.5050.523-0.634-0.7690.122
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Accounts Payable
Change in Accrued Expenses
Change in Payable / Accrued Expenses
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities-0.863-1.08-2.22-3.84-3.94
Capital Expenditures-0.0010-0.01-0.053
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items-6.794.46-0.524
Sale/Maturity of Investment
Purchase of Investments
Cash from Investing Activities-0.0010-6.794.45-0.578
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities0.8791.668.51-0.24.52
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash0.0150.583-0.4990.417-0.006